PLEURAL MESOTHELIOMA
Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to boost cancer immunotherapy
Disease control Recruiting nowThis study is testing a new oral drug called Alintegimod, given alongside standard immunotherapy drugs (ipilimumab and nivolumab), for people with advanced cancers that have spread. The main goals are to find a safe dose and see if the combination helps control the cancer. It is …
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug combo targets genetic weakness in tough cancers
Disease control Recruiting nowThis early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New italian cancer test aims to personalize treatment
Diagnosis Recruiting nowThis study is testing a new diagnostic platform called the Italian Tumor Chemogenomic Profiler (IT-TCP). Researchers will analyze tumor samples from 300 patients with various high-risk cancers to see if this detailed analysis can help guide treatment choices. The goal is to see i…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated Apr 02, 2026 14:58 UTC